| Dr Diana Margaret Deandrea, PHARMD | |
|
1710 Barton Rd, Redlands, CA 92373-5304 | |
| (909) 558-9225 | |
| (909) 558-9249 |
| Full Name | Dr Diana Margaret Deandrea |
|---|---|
| Gender | Female |
| Speciality | Pharmacist - Psychiatric |
| Location | 1710 Barton Rd, Redlands, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184897878 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1835P1300X | Pharmacist - Psychiatric | RPH 35876 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Diana Margaret Deandrea, PHARMD 582 E Parkdale Dr, San Bernardino, CA 92404-1766 Ph: (909) 881-3778 | Dr Diana Margaret Deandrea, PHARMD 1710 Barton Rd, Redlands, CA 92373-5304 Ph: (909) 558-9225 |
News Archive
Patients with suspected obstructive sleep apnea may no longer have to spend an expensive and uncomfortable night at a sleep center to monitor their sleep-disordered breathing. According to new research, those who performed sleep testing in their home with portable monitors showed similar improvements after three months of treatment with continuous positive airway pressure in daytime function as compared to patients who underwent overnight testing in a sleep center.
Type 2 diabetes (T2D) and osteoporosis often coexist in patients, but managing both conditions can be a challenge.
Metabolex, Inc. announced today that they have entered into a global development and license agreement with Ortho-McNeil-Janssen Pharmaceuticals, Inc. to further develop and discover compounds for the treatment of type 2 diabetes and other disorders. Under the agreement, OMJPI will receive an exclusive worldwide license to develop, manufacture, and commercialize several Metabolex programs that are currently at the preclinical stage.
Attention-deficit/hyperactivity disorder (ADHD) affects 5-9% of youth and is frequently treated with stimulant medications, such as methylphenidate and amphetamine products. A recent safety communication from the US Food and Drug Administration advised that all patients undergoing ADHD treatment be monitored for changes in heart rate or blood pressure.
Researchers on Friday released a study in the Lancet that found while "[m]ost countries in Latin America, Asia and the Middle East doubled their health budgets," countries in sub-Saharan Africa appear to have trimmed their health spending as donors have boosted their health aid, the Associated Press/Washington Post reports.
› Verified 3 days ago
Dr. Julie Mei Wah Plumtree, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 800 E Lugonia Ave, Redlands, CA 92374 Phone: 909-307-6964 | |
Khondker Masum Parvez, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2050 W Redlands Blvd, Redlands, CA 92373 Phone: 909-792-6260 Fax: 909-798-6672 | |
James Truong, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10620 Mountain View Ave Apt H, Redlands, CA 92373 Phone: 518-364-7514 | |
Dr. Umang Natvarlal Shah, DOCTOR OF PHARMACY Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 700 E Redlands Blvd Ste A, Redlands, CA 92373 Phone: 909-793-3568 Fax: 909-793-5492 | |
Roxana Lang, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 26001 Redlands Blvd, Redlands, CA 92373 Phone: 909-583-6943 | |
Joni Magat, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2 W Fern Ave, Redlands, CA 92373 Phone: 909-793-9398 Fax: 909-798-7748 | |
Janet Cantada, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2 W Fern Ave, Redlands, CA 92373 Phone: 909-793-3311 |